Development and validation of an automated, enzyme-mediated colorimetric assay of salicylate in serum.
This salicylate-specific assay can be adapted for use with most discrete analyzers, for rapid emergency or routine testing with small serum or plasma sample volumes and a single calibration. The basis of this method is as follows: salicylate monooxygenase (EC 1.14.13.1) converts salicylate to catechol in the presence of NADH; the catechol then reacts with 4-aminophenazone under alkaline conditions, catalyzed by manganese ions, to produce a red dye. Incorporation of an NADH-regenerating system, involving glucose and glucose dehydrogenase, into the enzyme reagent ensures that the working reagent is stable for more than two weeks. The standard curve is linear over the drug concentration range 0 to 5 mmol/L. The CV was less than 4% over 20 days. Results correlated well with those by the Trinder colorimetric method and an HPLC method. We saw no interference by any of 80 drugs we tested at therapeutic concentrations or by endogenous compounds in serum.
Morris
H C
HC
Department of Chemical Pathology, London Hospital Medical College, U.K.
Overton
P D
PD
Ramsay
J R
JR
Campbell
R S
RS
Hammond
P M
PM
Atkinson
T
T
Price
C P
CP
D001322:Autoanalysis; D002021:Buffers; D002396:Catechols / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D003124:Colorimetry; D004630:Emergencies; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D006899:Mixed Function Oxygenases; D009243:NAD; D011041:Poisoning / Q000097:blood; D012459:Salicylates / Q000097:blood* / Q000633:toxicity; D013501:Surface-Active Agents
D002021:Buffers; D002396:Catechols; D007202:Indicators and Reagents; D012459:Salicylates; D013501:Surface-Active Agents; D009243:NAD; D006899:Mixed Function Oxygenases; C022619:salicylate 1-monooxygenase